Jonathan Van-Tam on COVID’s Next Phase
By James Strachan, Julian Upton
April 14, 2026
Former UK Deputy Chief Medical Officer discusses new protein-based vaccines, declining uptake, and the ongoing risks of COVID-19
4 min read
False
By James Strachan, Julian Upton
April 14, 2026
Former UK Deputy Chief Medical Officer discusses new protein-based vaccines, declining uptake, and the ongoing risks of COVID-19
4 min read
April 10, 2026
Sample preparation, limits of detection, and structural determination – our experts return for part two to discuss the main analytical challenges associated with nitrosamines
11 min read
By Amanda M. Guiraldelli, Piotr Alvarez, Koen Sandra
April 9, 2026
The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges...
12 min read
April 7, 2026
Study reveals Fc fragment of antibody is essential for activating microglia to clear amyloid plaques
2 min read
April 6, 2026
Why vascularized tissues are gaining traction
7 min read
April 6, 2026
A new review unpacks how GMP standards, evolving regulations, and emerging production technologies are reshaping monoclonal antibody manufacturing
3 min read
April 6, 2026
Review charts rise of language models, AlphaFold, and generative AI in engineering next-generation therapeutics
2 min read
By Audrey Greenberg
March 30, 2026
From capital scarcity to clinical impact, execution and partnerships are redefining the industry’s next chapter.
5 min read
March 30, 2026
New framework combining LCA and network analysis reveals hidden leverage points for decarbonization in complex drug supply networks
1 min read
March 24, 2026
Modular automation with human oversight across laboratory and manufacturing scales
2 min read
False
False
False